Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
Jin GH; Hirano T; Murakami M; International Immunology, 2008, vol. 20, issue 6, p 783, ISSN 14602377. ISBN 14602377.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef